SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-020775
Filing Date
2018-08-09
Accepted
2018-08-09 08:43:28
Documents
82
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q jnp-10q_20180630.htm 10-Q 2750195
2 EX-10.1 jnp-ex101_208.htm EX-10.1 153650
3 EX-10.2 jnp-ex102_209.htm EX-10.2 443702
4 EX-10.3 jnp-ex103_210.htm EX-10.3 271083
5 EX-31.1 jnp-ex311_10.htm EX-31.1 8781
6 EX-31.2 jnp-ex312_9.htm EX-31.2 8719
7 EX-32.1 jnp-ex321_7.htm EX-32.1 5824
8 EX-32.2 jnp-ex322_6.htm EX-32.2 6081
  Complete submission text file 0001564590-18-020775.txt   10076328

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT jnp-20180630.xml EX-101.INS 2153674
10 XBRL TAXONOMY EXTENSION SCHEMA jnp-20180630.xsd EX-101.SCH 55387
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE jnp-20180630_cal.xml EX-101.CAL 67182
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE jnp-20180630_def.xml EX-101.DEF 192868
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE jnp-20180630_lab.xml EX-101.LAB 412722
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jnp-20180630_pre.xml EX-101.PRE 327288
Mailing Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110
Business Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110 617-639-1500
JUNIPER PHARMACEUTICALS INC (Filer) CIK: 0000821995 (see all company filings)

IRS No.: 592758596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10352 | Film No.: 181003557
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences